Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Investigative Dermatology|February 28, 2025
Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023Saskia Ingen-Housz-Oro, Ilaria Matei, Antoine Gaillet, et al.
American Journal of Ophthalmology|November 26, 2008
Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet diseaseJulie Gueudry, Bertrand Wechsler, Céline Terrada, et al.
Cornea|February 6, 2026
Magnetic Resonance Imaging and Keratopigmentation: A Systematic Review and Ex Vivo Study of Complications and Adverse EventsArnaud Gaulier, Lionel Nicol, Sabine Lefevre, et al.
Current Eye Research|April 2, 2020
Corneal Pharmacokinetics of Voriconazole and Posaconazole following Intrastromal Injection and Posaconazole Eye Drops Instillation in RatsJulie Gueudry, Laetitia Le Goff, Fabien Lamoureux, et al.
Cornea|September 25, 2025
Development of an Ex Vivo Model of Focal Corneal Desiccation to Investigate the Pathophysiology of Corneal Dellen and UlcersArnaud Gaulier, Thara Jaworski, Anais Vautier, et al.
RMD Open|August 28, 2019
Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohortGuillaume Morelle, Julie Gueudry, Florence Uettwiller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 4, 2026
Epidermal necrolysis sequelae: A cohort study on prevalence and risk factorsThanh Vy Nguyen, Thomas Bettuzzi, Karim Zaghbib, et al.
The Journal of Antimicrobial Chemotherapy|March 30, 2018
Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitisJulie Gueudry, Laetitia Le Goff, Patricia Compagnon, et al.
Antiviral Research|September 24, 2017
Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological studyAntoine Rousseau, David Boutolleau, Karine Titier, et al.
Ophthalmology|November 18, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkMathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, et al.
Pageof 5